Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd > $RVV $RVVTF - Great Post on Yahoo ! James - Thank U !!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by cool888on May 03, 2021 7:20pm
103 Views
Post# 33120354

RE:RE:RE:RE:$RVV $RVVTF - Great Post on Yahoo ! James - Thank U !!

RE:RE:RE:RE:$RVV $RVVTF - Great Post on Yahoo ! James - Thank U !!
1ottrunner wrote: Cool88, is it more likely that a clinical trial succeeds or fails?


cool888 wrote:
1ottrunner wrote: Nice dream but not likely.

If MF or Doc F had any data on this blinded study they would have to share it with us, not in a month, not in 2 weeks, right away.  ASAP sort of thing.

We can all dream of great trial results but until they are posted we have no idea, in fact it is just as LIKELY that they are moving to pre-clinical testing in severe illness because the trial has FAILED.

I am in investor, just like you, but the chance the trial fails is historically much more likely than success.


It's ALWAYS a pleasure to read your NEGATIVE posts ...

In coming weeks, EUA news !! O Yeah !!
 




BIG YES - SUCCESS ! my friend, in my opinion !!

Revive cannot discuss preliminary findings prior to the data being reviewed but it's very obvious the results are favorable or they would not be expanding the scope of the research to include the efficacy in sever covid.

EUA News Very Soon - GLTA folks !!

Got an interview at Google today!!! - GIF on Imgur


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities